McClain R M, Levin A A, Posch R, Downing J C
Department of Toxicology and Pathology, Hoffmann-LaRoche, Inc., Nutley, New Jersey 07110.
Toxicol Appl Pharmacol. 1989 Jun 15;99(2):216-28. doi: 10.1016/0041-008x(89)90004-5.
The effect of phenobarbital on thyroid function and the metabolism and biliary excretion of thyroxine in rats was determined. Phenobarbital, administered for 2 weeks at a dose of 100 mg/kg/day, resulted in an increase in hepatic and thyroid gland weights, decreased circulating levels of T4, T3 and rT3, and increased TSH levels in male and female rats. After 3 months of treatment liver and thyroid weights were still increased; however, hormone values were not as markedly affected indicating that the rats had partially compensated for the effect on thyroid function. In thyroidectomized rats the plasma clearance of thyroxine was increased with phenobarbital. In bile duct cannulated phenobarbital-treated male rats the hepatic uptake at 4 hr was markedly increased. Bile flow was increased and the 4-hr cumulative biliary excretion of administered radioactivity was increased by 42%. Most of the increase in the excretion (76%) was accounted for by an increase in the excretion of thyroxine-glucuronide in phenobarbital-treated rats. Hepatic thyroxine-glucuronyltransferase activity in phenobarbital-treated rats expressed as picomoles per milligram of protein was increased by 40%; enzyme activity per gram of liver was increased by about twofold which, coupled with increased hepatic weight, resulted in about a threefold increase in total hepatic thyroxine-glucuronyltransferase activity in phenobarbital-treated rats as compared to that of controls. Qualitatively similar effects on metabolism, excretion, and enzyme induction were noted in female rats; however, the magnitude of increase was less than that observed in male rats. It is concluded that the effect of phenobarbital on thyroid function in rats is primarily a result of its effects on the hepatic disposition of thyroid hormone. The induction of thyroxine-glucuronyltransferase appears to play an important role in the increased metabolism and excretion of thyroxine in phenobarbital-treated rats.
测定了苯巴比妥对大鼠甲状腺功能以及甲状腺素代谢和胆汁排泄的影响。以100mg/kg/天的剂量给予苯巴比妥2周,导致雄性和雌性大鼠肝脏和甲状腺重量增加,T4、T3和rT3的循环水平降低,TSH水平升高。治疗3个月后,肝脏和甲状腺重量仍增加;然而,激素值受影响程度不那么明显,表明大鼠已部分代偿了对甲状腺功能的影响。在甲状腺切除的大鼠中,苯巴比妥可增加甲状腺素的血浆清除率。在胆管插管的经苯巴比妥处理的雄性大鼠中,4小时时肝脏摄取显著增加。胆汁流量增加,给药放射性物质的4小时累积胆汁排泄增加了42%。排泄增加的大部分(76%)是由于经苯巴比妥处理的大鼠中甲状腺素葡萄糖醛酸苷排泄增加所致。以每毫克蛋白质的皮摩尔数表示,经苯巴比妥处理的大鼠肝脏甲状腺素葡萄糖醛酸基转移酶活性增加了40%;每克肝脏的酶活性增加了约两倍,这与肝脏重量增加相结合,导致经苯巴比妥处理的大鼠肝脏总甲状腺素葡萄糖醛酸基转移酶活性与对照组相比增加了约三倍。在雌性大鼠中也观察到了对代谢、排泄和酶诱导的定性相似的影响;然而,增加的幅度小于雄性大鼠。结论是,苯巴比妥对大鼠甲状腺功能的影响主要是其对甲状腺激素肝脏处置作用的结果。甲状腺素葡萄糖醛酸基转移酶的诱导似乎在经苯巴比妥处理的大鼠甲状腺素代谢和排泄增加中起重要作用。